Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children … (NCT07527104) | Clinical Trial Compass
RecruitingNot Applicable
Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial Hemorrhage
Vietnam60 participantsStarted 2025-12-15
Plain-language summary
This study evaluates the safety and preliminary efficacy of autologous bone marrow mononuclear cell transplantation combined with rehabilitation in children with neurological sequelae caused by hypoxic-ischemic brain injury or intracranial hemorrhage. Participants in the intervention group will receive autologous bone marrow aspiration, mononuclear cell transplantation via intrathecal route, and rehabilitation, while the control group will receive rehabilitation alone. Outcomes will be compared between groups over follow-up time points.
Who can participate
Age range6 Months – 18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Children diagnosed with cerebral palsy
* Age from 12 months to 72 months
* Cerebral palsy caused by hypoxic-ischemic brain injury or intracranial hemorrhage
* Gross Motor Function Classification System (GMFCS) level III to V
* Completed required laboratory tests according to the study protocol
* Written informed consent obtained from the child's parent or legal guardian
Exclusion Criteria:
* Children with acute infection at the time of screening or enrollment
* Children with severe coagulopathy or contraindications to bone marrow aspiration
* Children with severe systemic diseases (e.g., severe cardiac, hepatic, or renal failure)
* Children with contraindications to anesthesia or intrathecal transplantation procedures
* Children with a history of malignancy
* Children who are unable to participate in or complete the rehabilitation program
* Parents or legal guardians who do not provide informed consent
What they're measuring
1
Change in Gross Motor Function Measure (GMFM-88) total score from baseline to 12 months